2034
R. Sagar et al. / Carbohydrate Research 339 (2004) 2031–2035
1.3. Physicochemical and spectral data for compounds
2a–c and 3a–f
10.6 and 4.2 Hz, H-6b), 2.03 (s, 3H, COCH3); 13C NMR
(50 MHz, CDCl3): d 193.5 (C-1), 170.6 (COCH3), 153.0
(C-3), 134.7 (C-2), 138.1, 137.6, 128.9, 128.5, 128.3,
128.2 (CH2Ph), 77.1 (C-5), 73.7 (CH2Ph), 73.4 (C-4),
72.4 (CH2Ph), 68.0 (C-6), 21.4 (COCH3); FABMS: calcd
for C22H24O5, m=z 368; found, m=z 391 (Mþ+Na). Anal.
Calcd for C22H24O5: C, 71.73; H, 6.52. Found: C, 70.07;
H, 6.97.
1.3.1. (3S,4S,5R)-3,4,6-Tri-O-benzyl-2-deoxy-D-arabino-
hexopyranose acetate (2a). IR (neat, cmꢀ1): m 1694
1
(C@O), 968, 700; H NMR (200 MHz, CDC13): d 7.16–
7.32 (m, 30H, Pha and Phb), 6.24 (d, 1H, J 1.7 Hz, H-
1a), 5.65 (dd, 1H, J 11.6 and 2.7 Hz, H-1b), 4.38–4.90
(6d, 12H, J 10.7 Hz, CH2Pha and CH2Phb), 2.28 (ddd,
2H, J 13.44, 4.8, and 1.38 Hz, H-20a and H-20e), 2.03 and
2.09 (2s, 6H, 2 · COCH3), 1.91 (dd, 2H, J 11.09 and
5.5 Hz, H-2a and H-2e); 13C NMR (50 MHz, CDC13): d
169.7 (COCH3), 138.5, 138.8 (qC of Ph), 128.9, 128.8,
128.4, 128.3, 128.1, 128.0 (Ph), 92.6 (C-1), 78.0 (C-5),
77.3 (C-4), 75.6 (CH2Ph) 74.0 (C-3), 72.1 (CH2Ph), 69.0
(C-6), 34.7 (C-2), 21.5 (COCH3); FABMS: calcd for
C29H32O6, m=z 476; found, m=z 499 (Mþ+Na). Anal.
Calcd for C29H32O6: C, 73.10; H, 6.72. Found: C, 73.37;
H, 7.01.
1.3.5. (2E,4R,5R)-5-O-Acetyl-4,6-di-O-benzyl-2,3-dide-
D
oxy-aldehydo-
-threo-hex-2-enose (3b). ½aꢁ +7.5 (c
D
0.16, CH3OH); IR (neat, cmꢀ1): m 2815 (CH of CHO),
1
1742 (C@O), 702; H NMR (200 MHz, CDCl3): d 9.53
(d, 1H, J 7.7 Hz, H-1), 7.16–7.32 (m, 10H, 2 · CH2Ph),
6.69 (dd, 1H, J 15.8 and 6.2 Hz, H-3), 6.34 (dd, 1H, J
15.8 and 7.7 Hz, H-2), 5.19 (q, 1H, J 4.9 Hz, H-5), 4.39–
4.66 (m, 4H, 2 · CH2Ph), 3.75 (m, 1H, H-4), 3.66 (dd,
1H, J 10.6 and 5.2 Hz, H-6a), 3.55 (dd, 1H, J 10.6 and
4.2 Hz, H-6b), 2.06 (s, 3H, COCH3); 13C NMR
(50 MHz, CDCl3): d 193.3 (C-1), 170.6 (COCH3), 152.6
(C-3), 134.1 (C-2), 137.9, 137.6, 128.9, 128.8, 128.6,
128.5, 128.3, 128.2 (2 · CH2Ph), 76.9 (C-5), 73.8
(CH2Ph), 73.2 (C-4), 72.8 (CH2Ph), 68.2 (C-6), 21.3
(COCH3); FABMS: calcd for C22H24O5, m=z 368; found,
m=z 369 (Mþ+1). Anal. Cacld for C22H24O5: C, 71.73; H,
6.52. Found: C, 71.56; H, 7.01.
1.3.2. (3S,4R,5R)-3,4,6-Tri-O-benzyl-2-deoxy-D-lyxo-
hexopyranose acetate (2b). IR (neat, cmꢀ1): m 1744
1
(C@O), 966, 698; H NMR (200 MHz, CDC13): d 7.23–
7.35 (m, 30H, Pha and Phb), 6.26 (d, 1H, J 1.9 Hz, H-
1a), 5.65 (dd, 1H, J 11.6 and 2.7 Hz, H-1b), 4.36–4.96
(m, 12H, 3 · CH2Pha,b), 3.87–3.99 and 3.54–3.65 (2m,
10H, H-3a, H-3b, H-4a, H-4b, H-5a, H-5b, H-6a, and
H-6b), 2.28 (ddd, 2H, J 13.44, 4.8, and 1.38 Hz, H-20a
and H-20e), 2.03 and 2.07 (2s, 6H, 2 · COCH3), 1.91 (dd,
2H, J 11.09 and 5.5 Hz, H-2a and H-2e); 13C NMR
(50 MHz, CDC13): d 169.8 (COCH3), 139.1, 138.6,
138.5, 138.3, 128.8, 128.7, 128.5, 128.4, 128.2, 128.0,
127.8 (Ph), 92.8 (C-1), 74.4 (C-5), 74.3 (CH2Ph), 74.0 (C-
4), 72.5 (C-3), 70.8 (CH2Ph), 69.3 (C-6), 30.4 (C-2), 21.1
(COCH3); EIMS: calcd for C29H32O6, m=z 476; found,
338 (Mþ)BnOH)HCHO). Anal. Calcd for C29H32O6:
C, 73.10; H, 6.72. Found: C, 73.01; H, 7.03.
1.3.6. (2E,4S)-5-O-Acetyl-4-O-benzyl-2,3-dideoxy-alde-
hydo-
D
-glycero-pent-2-enose (3c). ½aꢁ +30.5 (c 0.14,
D
CH3OH); IR (neat, cmꢀ1): m 2810 (CH of CHO), 1680
(C@O), 1200 (C–O), 850; 1H NMR (200 MHz, CDC13):
d 9.61 (d, 1H, J 7.6 Hz, H-1), 7.33 (br s, 5H, CH2Ph),
6.75 (dd, 1H, J 15.8 and 7.9 Hz, H-3), 6.38 (dd, 1H, J
15.8 and 7.6 Hz, H-2), 4.67 (d, 1H, J 12.0 Hz, CH2Ph),
4.53 (d, 1H, J 12.0 Hz, CH2Ph), 4.32 (m, 1H, H-4), 4.22
(m, 2H, H-5), 2.06 (s, 3H, COCH3); 13C NMR (50 MHz,
CDC13): d 193.3 (C-1), 170.0 (COCH3), 152.5 (C-3),
137.6 (qC of CH2Ph), 134.2 (C-2), 129.0, 128.5, 128.2
(CH2Ph), 76.1 (C-5), 72.2 (CH2Ph), 65.2 (C-4), 21.2
(COCH3); FABMS: calcd for C14H16O4, m=z 248; found,
m=z 249 (Mþ+1). Anal. Calcd for C14H16O4: C, 67.72; H,
6.49. Found: C, 66.36; H, 6.76.
1.3.3. (3R,4S)-3,4-Di-O-benzyl-2-deoxy-D-erythro-pento-
1
pyranose acetate (2c). H NMR (200 MHz, CDC13): d
7.25–7.33 (m, 10H, 2 · CH2Ph); 6.23 (br s, 1H, H-1),
4.57–4.71 (m, 4H, 2 · CH2Ph), 4.11–4.23 (m, 1H, H-3),
3.85–3.99 (m, 1H, H-4), 3.74 (m, 2H, H-5a and H-5e),
2.36 (d, 1H, J 14.0 Hz, H-2a), 2.05 (s, 3H, COCH3), 1.91
(d, 1H, J 14.2 Hz, H-2e); FABMS: calcd for C21H24O5,
m=z 356; found, m=z 355 (Mþ)1).
1.3.7.
hydo-
(2E,4S,5R)-4,6-Di-O-methyl-2,3-dideoxy-alde-
-erythro-hex-2-enose (3d). ½aꢁ +24.0 (c 0.035,
D
D
1.3.4. (2E,4S,5R)-5-O-Acetyl-4,6-di-O-benzyl-2,3-dide-
oxy-aldehydo-
CHCl3); IR (neat, cmꢀ1): m 3435 (O–H), 2930 (@C–
1
D
-erythro-hex-2-enose (3a). ½aꢁ +21.7 (c
H), 1687 (C@O), 1457 (C@C), 1110 (C–O); H NMR
D
0.15, CH3OH); IR (neat, cmꢀ1): m 2810 (CH of CHO),
1700 (C@O), 966, 698; H NMR (200 MHz, CDC13): d
(200 MHz, CDCl3): d 9.63 (d, 1H J 7.8 Hz, H-1),
6.85 (dd, 1H, J 15.8 and 5.7 Hz, H-3), 6.32 (dd, 1H, J
15.8 and 7.8 Hz, H-2), 3.95 (t, 1H, J 5.7 Hz, H-4), 3.87
(t, 1H, J 4.5 Hz, H-5), 3.48 (m, 2H, H-6), 3.39 (s, 3H,
OCH3), 3.38 (s, 3H, OCH3); 13C NMR (50 MHz,
CDC13): d 193.6 (C-1), 153.8 (C-3), 134.3 (C-2), 81.5 (C-
4), 73.1 (C-6), 72.4 (C-5), 59.6 and 58.3 (2 · OCH3);
1
9.64 (d, 1H, J 7.7 Hz, H-1), 7.16–7.32 (m, 10H,
2 · CH2Ph), 6.72 (dd, 1H, J 15.8 and 6.2 Hz, H-3), 6.30
(dd, 1H, J 15.8 and 7.7 Hz, H-2), 5.17 (q, 1H, J 5.0 Hz,
H-5), 4.35–4.65 (m, 4H, 2 · CH2Ph), 3.75 (m, 1H, H-4),
3.72 (dd, 1H, J 10.6 and 5.2 Hz, H-6a), 3.61 (dd, 1H, J